CollPlant Biotechnologies Q4 Adj EPS $(0.35) Misses $(0.07) Estimate, Sales $299.00K Miss $8.56M Estimate
CollPlant Biotechnologies Q4 Adj EPS $(0.35) Misses $(0.07) Estimate, Sales $299.00K Miss $8.56M Estimate
CollPlant Biotechnologies第四季度经调整后的每股收益美元（0.35美元）未达到预期（0.07美元），销售额为29.9万美元，低于856万美元的预期
CollPlant Biotechnologies (NASDAQ:CLGN) reported quarterly Adj losses of $(0.35) per share which missed the analyst consensus estimate of $(0.07) by 400 percent. This is unchanged from the same period last year. The company reported quarterly sales of $299.00 thousand which missed the analyst consensus estimate of $8.56 million by 96.51 percent. This is a 415.52 percent increase over sales of $58.00 thousand the same period last year.
CollPlant Biotechnologies（纳斯达克股票代码：CLGN）公布的季度调整后每股亏损为0.35美元（0.35美元），比分析师普遍预期的0.07美元（0.07美元）低400％。这与去年同期相比没有变化。该公司公布的季度销售额为29.9万美元，比分析师普遍预期的856万美元低96.51％。这比去年同期的58,000美元的销售额增长了415.52％。